transplantation

[Blood] The authors discuss the history, preclinical studies, and successful translation of CD4 + CD25 + FoxP3 + Tregs in the context of allogeneic hematopoietic cell transplantation.

The animal organ kept Tim Andrews off dialysis for 271 days and represents the first time a pig kidney has been used as a bridge to human organ transplantation

More than three-quarters of donated lungs offered for transplantation are not used, according to the UK's National Institute for Health and Care Excellence, contributing to a chronic shortage of organs for patients with end-stage lung disease.

WEDNESDAY, Sept. 9, 2026 — A genetically altered pig kidney helped keep a man alive for one year while he awaited a permanent human organ transplant, a new paper says.Kidney failure patient Tim Andrews, 67, successfully lived with a pig kidney...

IntroductionHeart transplantation (HTX), a treatment for end-stage heart failure, is accompanied by substantial psychological and physical strain for recipients. Many individuals develop Donor and Donation Images (DDI), referring to the thoughts and emotions directed toward the donor and/or the transplanted organ. The present study aims to systematically quantify the content dimensions of DDI and…

Skip to content

For the first time, genetically modified pig kidneys keep two kidney failure patients alive long enough to get human kidneys.

(NBC News) – The transplant led to “sustained dialysis independence” for nearly nine months before Tim Andrews, now 68, received a human kidney earlier this year, according to The Lancet. A New Hampshire man, at death’s door 1 ½ years … Read More

Tim Andrews, who had end-stage kidney disease, was 66 when he received the pig kidney in January 2025

Tim Andrews was the first patient to receive a genetically modified pig kidney as a “bridge” to a human organ transplant.

A pig kidney transplant worked for a record nine months. This enabled the recipient to stay off dialysis for longer while waiting for a suitable human donor's kidney to become available

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance xenografts.

A new risk stratification model developed by Northwestern Medicine scientists may help better identify patients who have a lower risk of kidney transplant rejection, which can inform more personalized treatment and care strategies that present fewer adverse side effects, as detailed in a recent study published in Nature Communications. The post Identifying Patients at Lower Risk for Kidney Transp…

A surgical team has performed the world's first-reported robotic double transplant of a liver and kidney at WashU Medicine and Barnes-Jewish Transplant Center.

The Hidden Organ Transplant Threat — CMV — Dr. Neil Inhaber, MD, FRCPC — Head, Marketed Products and Neuroscience, Global Medical Affairs, Takeda. Every year, hundreds of thousands of people around the world receive life-saving organ transplants — new hearts, kidneys, lungs, and livers that offer patients a second chance at life. But transplantation is […]

A new study led by researchers at Johns Hopkins Medicine found that a simple urine test performed on deceased kidney donors could help doctors make better transplant decisions, giving more people access to successful kidney transplants while reducing the number of deceased donor kidneys that go unused.

A new study led by researchers at Johns Hopkins Medicine found that a simple urine test performed on deceased kidney donors could help doctors make better transplant decisions, giving more people access to successful kidney transplants while reducing the number of deceased donor kidneys that go unused.

Long‑term outcomes after liver transplantation remain hampered by complications linked to intensive immunosuppression--infections, cardiovascular events, kidney dysfunction, and metabolic disorders affect 10% to 40% of recipients.

Long‑term outcomes after liver transplantation remain hampered by complications linked to intensive immunosuppression--infections, cardiovascular events, kidney dysfunction, and metabolic disorders affect 10% to 40% of recipients.